• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青蒿素:作用机制与耐药性潜力

Artemisinins: mechanisms of action and potential for resistance.

作者信息

Krishna Sanjeev, Uhlemann Anne-Catrin, Haynes Richard K

机构信息

Department of Cellular and Molecular Medicine, Infectious Diseases, St. George's Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK.

出版信息

Drug Resist Updat. 2004 Aug-Oct;7(4-5):233-44. doi: 10.1016/j.drup.2004.07.001.

DOI:10.1016/j.drup.2004.07.001
PMID:15533761
Abstract

Artemisinins form the most important class of antimalarial currently available, particularly because they are effective against parasites resistant to almost all the other classes. Their mechanism of action is controversial. Some aspects of this controversy are reviewed here. Whilst there is no clinical resistance yet identified to artemisinins, the potential to examine the relationship between polymorphisms in PfATP6 (a target of artemisinins) in multidrug resistant isolates of Plasmodium falciparum, is also discussed.

摘要

青蒿素是目前最重要的一类抗疟药物,特别是因为它们对几乎所有其他类别的抗药寄生虫都有效。它们的作用机制存在争议。本文回顾了这一争议的一些方面。虽然尚未发现对青蒿素的临床耐药性,但也讨论了研究恶性疟原虫多药耐药分离株中PfATP6(青蒿素的一个靶点)多态性之间关系的可能性。

相似文献

1
Artemisinins: mechanisms of action and potential for resistance.青蒿素:作用机制与耐药性潜力
Drug Resist Updat. 2004 Aug-Oct;7(4-5):233-44. doi: 10.1016/j.drup.2004.07.001.
2
Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: implications for the molecular mechanism of action of the artemisinins.对映体1,2,4 - 三氧杂环己烷对恶性疟原虫显示出同等的体外抗疟活性:对青蒿素作用分子机制的启示。
Chembiochem. 2005 Nov;6(11):2048-54. doi: 10.1002/cbic.200500048.
3
Potentiation of antimalarial drug action by chlorpheniramine against multidrug-resistant Plasmodium falciparum in vitro.氯苯那敏在体外增强抗疟药物对多重耐药恶性疟原虫的作用
Parasitol Int. 2006 Sep;55(3):195-9. doi: 10.1016/j.parint.2005.11.058. Epub 2006 Jun 5.
4
Artemisinins target the SERCA of Plasmodium falciparum.青蒿素作用于恶性疟原虫的肌浆网钙ATP酶。
Nature. 2003 Aug 21;424(6951):957-61. doi: 10.1038/nature01813.
5
Antimalarial activities of (+)-deoxoartemisitene and its novel C-11, 13 derivatives.(+)-脱氧青蒿烯及其新型C-11、13衍生物的抗疟活性。
Bioorg Med Chem Lett. 2004 Apr 19;14(8):2001-3. doi: 10.1016/j.bmcl.2003.12.104.
6
In vitro activity of artemisone compared with artesunate against Plasmodium falciparum.青蒿酮与青蒿琥酯对恶性疟原虫的体外活性比较。
Am J Trop Med Hyg. 2006 Oct;75(4):637-9.
7
Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo.新型半合成内过氧化物青蒿酮在体外和体内的抗疟疗效及药物相互作用
J Antimicrob Chemother. 2007 Apr;59(4):658-65. doi: 10.1093/jac/dkl563. Epub 2007 Mar 2.
8
Synthesis and biological evaluation of extraordinarily potent C-10 carba artemisinin dimers against P. falciparum malaria parasites and HL-60 cancer cells.针对恶性疟原虫和HL-60癌细胞的超强C-10碳青霉烯青蒿素二聚体的合成及生物学评价
Bioorg Med Chem. 2009 Feb 1;17(3):1325-38. doi: 10.1016/j.bmc.2008.12.017. Epub 2008 Dec 24.
9
Identification of a 1,2,4,5-tetraoxane antimalarial drug-development candidate (RKA 182) with superior properties to the semisynthetic artemisinins.鉴定出一种1,2,4,5-四氧六环抗疟药物研发候选物(RKA 182),其性能优于半合成青蒿素。
Angew Chem Int Ed Engl. 2010 Aug 2;49(33):5693-7. doi: 10.1002/anie.201001026.
10
Interaction of artemisinins with oxyhemoglobin Hb-FeII, Hb-FeII, carboxyHb-FeII, heme-FeII, and carboxyheme FeII: significance for mode of action and implications for therapy of cerebral malaria.青蒿素与氧合血红蛋白 Hb-FeII、Hb-FeII、碳氧血红蛋白 FeII、血红素 FeII 和碳氧血红素 FeII 的相互作用:对作用模式的意义及对脑型疟疾治疗的影响。
ChemMedChem. 2009 Dec;4(12):2045-53. doi: 10.1002/cmdc.200900342.

引用本文的文献

1
Exploring the anticancer potential of R. tridentata extracts: a cytotoxicity study against human prostate cancer cell lines (LNCaP and DU145).探索三叉叶悬钩子提取物的抗癌潜力:针对人前列腺癌细胞系(LNCaP和DU145)的细胞毒性研究。
Med Oncol. 2025 Sep 5;42(10):463. doi: 10.1007/s12032-025-02953-5.
2
, a Promising Tool for Integrated Parasite Control.一种用于综合寄生虫控制的有前景的工具。 (原英文文本似乎不完整,仅根据现有内容翻译)
J Parasitol Res. 2025 Jul 1;2025:9987439. doi: 10.1155/japr/9987439. eCollection 2025.
3
The Beneficial Use of , Artemisinin, and Other Compounds in Animal Health.
青蒿素及其他化合物在动物健康方面的有益用途。
Animals (Basel). 2025 May 8;15(10):1359. doi: 10.3390/ani15101359.
4
Unlocking the potential of for artemisinin production: current insights and emerging strategies.挖掘青蒿素生产的潜力:当前见解与新兴策略。
3 Biotech. 2025 Jun;15(6):164. doi: 10.1007/s13205-025-04332-3. Epub 2025 May 13.
5
Antimalarial and antioxidant activities of novel artesunate-ellagic acid hybrid compound and .新型青蒿琥酯-鞣花酸杂合化合物的抗疟和抗氧化活性以及……(原文此处不完整)
Front Pharmacol. 2024 Jun 18;15:1192659. doi: 10.3389/fphar.2024.1192659. eCollection 2024.
6
Photoaffinity probe-based antimalarial target identification of artemisinin in the intraerythrocytic developmental cycle of .基于光亲和探针的青蒿素在疟原虫红细胞内发育周期中的抗疟靶点鉴定 。 你提供的原文似乎不完整,句末的“of.”后面缺少具体内容。
Imeta. 2024 Feb 19;3(2):e176. doi: 10.1002/imt2.176. eCollection 2024 Apr.
7
Alternative first-line malaria treatment.替代一线疟疾治疗。
Ann Afr Med. 2024 Jan-Mar;23(1):5-12. doi: 10.4103/aam.aam_35_23.
8
Diagnosis and management of malaria in the intensive care unit.重症监护病房中疟疾的诊断与管理
J Intensive Med. 2023 Nov 3;4(1):3-15. doi: 10.1016/j.jointm.2023.09.002. eCollection 2024 Jan.
9
Molecular Interactions Identified by Two-Dimensional Analysis-Detailed Insight into the Molecular Interactions of the Antimalarial Artesunate with the Target Structure β-Hematin by Means of 2D Raman Correlation Spectroscopy.二维分析鉴定的分子相互作用 - 通过二维拉曼相关光谱技术深入了解抗疟药青蒿琥酯与靶结构β-血影蛋白的分子相互作用。
Anal Chem. 2023 Aug 29;95(34):12719-12731. doi: 10.1021/acs.analchem.3c01415. Epub 2023 Aug 16.
10
Recent Updates on Interaction Studies and Drug Delivery of Antimalarials with Serum Albumin Proteins.近期关于抗疟药物与血清白蛋白相互作用研究和药物递送的更新。
Curr Med Chem. 2024;31(25):3925-3953. doi: 10.2174/0929867330666230509121931.